Uzm. Dr. Erdoğan Şeyran

Serum Procalcitonin for the Diagnosis of Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis: A Prospective Study

Eurasian Journal of Medical Advances, 2026

DOI 10.14744/ejma.267011 Frei zugänglicher VolltextQuelle: OpenAlex

Association between gastric epithelial dysplasia and clinicopathological characteristics and overall survival in patients with metastatic gastric adenocarcinoma

Journal of Medicine and Palliative Care, 2026

DOI 10.47582/jompac.2013606 Frei zugänglicher VolltextQuelle: ORCID

Development of a Clinicopathological Prognostic Model and Risk Classification to Predict Disease-Free Survival in Patients with Gastric Adenocarcinoma Following Neoadjuvant Chemotherapy and Curative Gastrectomy

Current Oncology, 2026

DOI 10.3390/curroncol33090500 PMID 42782847 Frei zugänglicher VolltextQuelle: ORCID

Association of ABO and Rh blood groups with survival and clinicopathological characteristics in patients with gastric adenocarcinoma: a single-center retrospective study

Journal of Current Hematology & Oncology Research, 2026

DOI 10.51271/jchor-0090 Frei zugänglicher VolltextQuelle: ORCID

Integrating molecular and clinical determinants of survival in a real-world glioblastoma cohort

Journal of Medicine and Palliative Care, 2026

DOI 10.47582/jompac.1850445 Frei zugänglicher VolltextQuelle: ORCID

Beyond IMDC: do expanded models improve survival discrimination in metastatic renal cell carcinoma? A real-world cohort study

Frontiers in Oncology, 2026

DOI 10.3389/fonc.2026.1887870 PMID 42597456 Frei zugänglicher VolltextQuelle: ORCID

Pathological Complete Response and Residual Disease Patterns After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Clinical and Laboratory Associations

Cancers, 2026

DOI 10.3390/cancers18182983 PMID 42794949 Frei zugänglicher VolltextQuelle: ORCID

Prognostic Factors in Upper Gastrointestinal Neuroendocrine Carcinoma: A Retrospective Cohort Study of Clinicopathological Features and Survival Outcomes

Cancer Management and Research, 2026

DOI 10.2147/cmar.s618644 PMID 42483270 Frei zugänglicher VolltextQuelle: ORCID

Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer

Journal of Oncology Pharmacy Practice, 2026

DOI 10.1177/10781552231156521 PMID 36760158 11 Zitationen (OpenAlex) Quelle: ORCID

Association of Tumor Distribution Pattern with Stage at Diagnosis and Presentation Pattern in Patients with Invasive Breast Cancer

Bagcilar Medical Bulletin, 2026

DOI 10.4274/bmb.galenos.2026.16046 Frei zugänglicher VolltextQuelle: OpenAlex

Inflammatory and Nutritional Biomarkers for Overall Survival in Gastric Adenocarcinoma: Comparative Performance and Exploratory Temporal Patterns

Diagnostics, 2026

DOI 10.3390/diagnostics16213459 Frei zugänglicher VolltextQuelle: OpenAlex

Chat GPT Performance in Multi-Disciplinary Boards—Should AI Be a Member of Cancer Boards?

Healthcare, 2025

DOI 10.3390/healthcare13182254 PMID 41008386 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study

Cureus, 2023

DOI 10.7759/cureus.35710 PMID 36875256 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Adjuvant Capecitabine after Neoadjuvant Chemotherapy in Triple Negative Breast Cancer with Lymph Node Metastasis

Journal of the College of Physicians and Surgeons Pakistan, 2023

DOI 10.29271/jcpsp.2023.09.1012 PMID 37691363 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Vortex keratopathy associated with ribociclib

Journal of Oncology Pharmacy Practice, 2023

DOI 10.1177/10781552221101799 PMID 35570741 10 Zitationen (OpenAlex) Quelle: ORCID

Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma

Journal of Oncological Sciences, 2022

DOI 10.37047/jos.2022-90679 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors

Cancer Biomarkers, 2022

DOI 10.3233/cbm-210455 PMID 35001878 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID